マーケットレポート詳細

合成生物学(Synsethic Biology)：世界市場2026年予測

Synthetic Biology: Global Markets

出版元：BCC Research 　 出版元について
発行年：2022年2月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文344ページになります。
商品コード：BCC382

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

合成生物学の世界市場規模は2021年で95億ドル、2026年に332億ドルへと拡大すると予測されています。同市場の平均年成長率は28.4%で推移する見込みです。
当レポートでは、合成生物学の市場/技術的背景、合成生物学アプリケーション、各種セグメント別市場分析、合成生物学産業、特許、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆概要

・このレポートでカバーされている合成生物学技術
・バリューチェーン分析
・合成生物学の概要
・合成生物学の開発段階
・合成生物学の市場成長推進力
・エンドユーザー産業別の合成生物学の世界市場
・製品と技術のライフサイクル
・合成生物学産業
・COVID-19による合成生物学市場への影響

◆技術的背景

・ユニークな市販の合成生物学製品
・生物学におけるパラダイムシフト
・合成生物学技術の概要
・実現技術
・遺伝子ドライブ
・バイオインフォマティクステクノロジー
・生物学的コンポーネントと統合システム技術
・実現製品
・経路工学
・現在のガバナンスと規制

◆合成生物学アプリケーション

・テクノロジーアプリケーションの実現
・生物学的コンポーネントと統合システムアプリケーション
・実現した製品アプリケーション

◆合成生物学産業

・合成生物学産業への投資
・産業バイオテクノロジーバリューチェーン
・業界の構造
・製品と技術のライフサイクル
・シーケンシング機器産業
・ロングリードシーケンス産業
・DNA合成産業
・遺伝子編集産業
・合成生物学生物設計および生産産業
・ソフトウェア産業
・農業産業
・コンシューマー製品産業
・化粧品/スキンケア産業
・食品/飲料産業
・ヘルスケア産業
・工業用化学品産業
・無細胞システム産業
・業界の買収と戦略的提携

◆合成生物学市場

業界の成長-原動力

エンドユーザー産業別市場
・研究
・ヘルスケア
・工業用化学品
・農業
・コンシューマー
・食品/飲料
※市場予測データ-2026年掲載
※製品タイプ別のデータ掲載

製品タイプ別市場
・実現要素製品(Enabling Product)
・合成生物学的コンポーネント
・統合システム
・実現製品(Enabled Product)
※市場予測データ-2026年掲載
※エンドユーザー産業別のデータ掲載

地域別市場
・合成生物学製品
・実現要素製品(Enabling Product)
・コア製品
・実現製品(Enabled Product)
※地域別に、市場予測データ-2026年掲載

◆特許

・基礎特許
・合成生物学の特許分析
・シーケンシング関連の特許問題
・遺伝子編集関連の特許
・遺伝子編集特許：Sangamoケーススタディ

◆主要企業プロフィール

・AGILENT TECHNOLOGIES INC.
・AMYRIS INC.
・CODEXIS INC.
・EUROFINS SCIENTIFIC
・GENSCRIPT
・GINKGO BIOWORKS
・MERCK KGAA
・NOVOZYMES A/S
・THERMO FISHER SCIENTIFIC INC.
・TWIST BIOSCIENCE
・VIRIDOS

（その他企業）
・20N LABS INC.
・ABEONA THERAPEUTICS LLC
・ACTIVE MOTIF
・AEMETIS INC.
・AGRIVIDA INC.
・味の素株式会社
・ALGENUITY
・AMBRX INC.
・AMFORA INC.
・ANSA BIOTECHNOLOGIES INC.
・ANTHEIA INC.
・ARBOR BIOTECHNOLOGIES INC.
・ARCADIA BIOSCIENCES INC.
・ARCTURUS THERAPEUTICS INC.
・ARDRA BIO INC.
・ARZEDA CORP.
・ASTRAZENECA PLC
・ATG BIOSYNTHETICS GMBH
・ATUM
・AVECIA
・AZARGEN BIOTECHNOLOGIES PTY., LTD.
・AZITRA INC.
（上記を含む全175企業掲載）

(全344頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and for Whom
What's New in This Update?
Scope and Format
Methodology
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

Synthetic Biology Technologies Covered in this Report
Value Chain Analysis
Synthetic Biology Overview
Development Stage of Synthetic Biology
Forces Driving the Growth of the Market for Synthetic Biology
Global Market for Synthetic Biology by End-User Industry
Product and Technology Life Cycles
Synthetic Biology Industry
Impact of COVID-19 on the Global Market for Synthetic Biology

Chapter 4 Technology Background

Introduction

  • Synthetic Biology Defined
  • Synthetic Biology History

Unique Commercially Available Synthetic Biology Products

  • Leghemoglobin
  • Sitgaliptin
  • Hyaline
  • PROVEN, a Biological Nitrogen Fertilizer for Corn by Pivot Bio
  • Kymriah
  • Calyno

Paradigm Shift in Biology
Synthetic Biology Technology Overview
Enabling Technologies

  • DNA-Synthesis and DNA-Sequencing Cost Trends
  • DNA-Synthesis Technologies
  • Microfluidic Technologies
  • Next-Generation Sequencing Technologies
  • Gene Editing

Gene Drives
Bioinformatics Technologies
Biologic Components and Integrated Systems Technologies

  • Synthetic DNA
  • BioBrick Parts
  • Minimal Genomes and Chassis Organisms

Enabled Products
Pathway Engineering

  • Research and Development Applications
  • Synthetic Biology and the Microbiome
  • Synthetic Biology in Biofuels Feedstocks
  • Synthetic Biology Microbiome Initiatives

Current Governance and Regulations

  • U.S. Regulations
  • International Regulations

Chapter 5 Synthetic Biology Applications

Enabling Technologies Applications
Biologic Components and Integrated Systems Applications

  • Synthetic Genes
  • BioBrick Parts
  • Integrated Systems

Enabled Products Applications

  • Pharmaceuticals
  • Industrial Biotechnology Applications
  • Agricultural Applications
  • Data Storage Applications

Chapter 6 Synthetic Biology Industry

Investment in Synthetic Biology Industry
Industrial Biotechnology Value Chain
Industry Structural Forces
Products and Technology Life Cycle
Sequencing Instruments Industry
Long-Read Sequencing Industry
DNA Synthesis Industry

  • Oligos as Therapeutics
  • Gene Synthesis Workflow
  • Gene Synthesis Value Chain
  • Synthetic Gene Market Segments

Gene-Editing Industry
Synthetic Biology Organism Design and Foundries Industry
Software Industry
Agriculture Industry
Consumer Products Industry
Cosmetics and Skin Care Industry
Food and Beverage Industry
Healthcare Industry
Industrial Chemicals Industry
Cell-Free System Industry
Industry Acquisitions and Strategic Alliances

Chapter 7 Global Market for Synthetic Biology

Industry Growth-Driving Forces

  • DNA Read, Write and Edit Technologies
  • Growing Role of Designer Organisms
  • Speeding up of Commercialization Pathways
  • Growth in Synthetic Biology Foundries
  • Increasing Research and Development Investment by Pharma Companies

Global Market for Synthetic Biology by End-User Industry

  • Research Market
  • Healthcare Market
  • Industrial Chemicals Market
  • Agriculture Market
  • Consumer Market
  • Food and Beverage Market

Global Market for Synthetic Biology by Product Type

  • Enabling Products Market
  • Synthetic Biologic Components Market
  • Integrated Systems Market
  • Enabled Products Market

Geographic Markets

  • Synthetic Biology Products by Region
  • Enabling Products Market by Region
  • Core Products Market by Region
  • Enabled Products Market by Region

Chapter 8 Patents

Introduction
Foundational Patents
Synthetic Biology Patent Analysis
Sequencing-Related Patent Issues
Gene Editing-Related Patents
Gene Editing Patents: Sangamo Case Study

Chapter 9 Company Profiles

Key Market Players

  • AGILENT TECHNOLOGIES INC.
  • AMYRIS INC.
  • CODEXIS INC.
  • EUROFINS SCIENTIFIC
  • GENSCRIPT
  • GINKGO BIOWORKS
  • MERCK KGAA
  • NOVOZYMES A/S
  • THERMO FISHER SCIENTIFIC INC.
  • TWIST BIOSCIENCE
  • VIRIDOS

Other Players

  • 20N LABS INC.
  • ABEONA THERAPEUTICS LLC
  • ACTIVE MOTIF
  • AEMETIS INC.
  • AGRIVIDA INC.
  • AJINOMOTO CO., INC.
  • ALGENUITY
  • AMBRX INC.
  • AMFORA INC.
  • ANSA BIOTECHNOLOGIES INC.
  • ANTHEIA INC.
  • ARBOR BIOTECHNOLOGIES INC.
  • ARCADIA BIOSCIENCES INC.
  • ARCTURUS THERAPEUTICS INC.
  • ARDRA BIO INC.
  • ARZEDA CORP.
  • ASTRAZENECA PLC
  • ATG BIOSYNTHETICS GMBH
  • ATUM
  • AVECIA
  • AZARGEN BIOTECHNOLOGIES PTY., LTD.
  • AZITRA INC.
  • BASF AG
  • BAYER AG
  • BEAM THERAPEUTICS INC.
  • BENCHLING
  • BENSON HILL BIOSYSTEMS INC.
  • BIO BASIC INC.
  • BIOGEN INC.
  • BIOMAX INFORMATICS AG
  • BIOMX LTD.
  • BIONEER CORP.
  • BIO S&T INC.
  • BIOSYNTIA APS
  • BLUEBIRD BIO INC.
  • BOLT THREADS INC.
  • BRISTOL-MYERS SQUIBB CO.
  • CALYSTA INC.
  • CALYXT INC.
  • CARGILL INC.
  • CARIBOU BIOSCIENCES INC.
  • CRISPR THERAPEUTICS
  • CASZYME
  • CATALOG TECHNOLOGIES, INC.
  • CELLECTIS SA
  • CENTRIENT PHARMACEUTICALS
  • CHAIN BIOTECHNOLOGY LTD.
  • CIBUS INC.
  • C-LECTA GMBH
  • CODAGENIX INC.
  • COLORIFIX LTD.
  • CORBION
  • CRONOS GROUP
  • CROWN LABORATORIES INC.
  • DANAHER CORP.
  • DEMURIS LTD.
  • DNA SCRIPT
  • DOVETAIL GENOMICS LLC
  • DOWDUPONT INC.
  • EDIGENE INC.
  • EDITAS MEDICINE INC.
  • ELIGO BIOSCIENCE SAS
  • ENDLESS WEST
  • ENEVOLV INC.
  • EPOCH LIFE SCIENCE INC.
  • EVONETIX
  • EVOLVA SA
  • EXXONMOBIL CORP.
  • G+FLAS LIFE SCIENCES INC.
  • GEA ENZYMES
  • GELTOR INC.
  • GENEMED SYNTHESIS INC.
  • GENERAY BIOTECH CO., LTD.
  • GENOMATICA
  • GENUS PLC
  • GEVO INC.
  • GILEAD SCIENCES INC.
  • GLAXOSMITHKLINE PLC
  • GLOBAL BIOENERGIES
  • GLOWEE- UNREASONABLE GROUP
  • GLYCOSBIO FOOD SCIENCES
  • GLYCOSYN LLC
  • GOODYEAR TIRE & RUBBER CO.
  • HELIXWORKS TECHNOLOGIES LTD.
  • HOMOLOGY MEDICINES INC.
  • HORIZON DISCOVERY GROUP PLC
  • HUVEPHARMA
  • ILLUMINA INC.
  • IMPOSSIBLE FOODS INC.
  • INDUSTRIAL MICROBES INC.
  • INGENZA LTD.
  • INOVIO PHARMACEUTICALS INC.
  • INSCRIPTA INC.
  • INTELLIA THERAPEUTICS INC.
  • INTERNATIONAL BUSINESS MACHINES
  • JOYN BIO
  • KANEKA CORP.
  • KWS SAAT SE
  • LABGENIUS LTD.
  • LANZATECH
  • LATTICE AUTOMATION INC.
  • LC SCIENCES
  • LCY CHEMICAL CORP.
  • LGC GROUP
  • LOCUS BIOSCIENCES
  • LOGICBIO THERAPEUTICS
  • LUMEN BIOSCIENCE
  • LYGOS INC.
  • MEISSA VACCINES, INC.
  • MICROSYNBIOTIX
  • MICROBYRE, INC.
  • MICROSOFT CORP.
  • MILIS BIO LTD.
  • MODERN MEADOW
  • MODULAR GENETICS INC.
  • MOLECULAR ASSEMBLIES INC.
  • MORPHOSYS AG
  • MOTIF INGREDIENTS
  • NEW ENGLAND BIOLABS
  • NOVARTIS PHARMA AG
  • NOVOME BIOTECHNOLOGIES INC.
  • NOVVI LLC
  • NUCELIS LLC
  • NUCLERA NUCLEICS LTD.
  • OMEGA BIO-TEK INC.
  • ORAGENICS INC.
  • OXFORD BIOMEDICA PLC
  • PAIRWISE PLANTS INC.
  • PFIZER INC.
  • PHIO PHARMACEUTICALS CORP.
  • PHYTOWELT GREEN TECHNOLOGIES GMBH
  • PIVOT BIO
  • POSEIDA THERAPEUTICS INC.
  • PRECISION BIOSCIENCES INC.
  • PROKARIUM HOLDINGS LTD.
  • PROMEGA CORP.
  • PTC THERAPEUTICS INC.
  • RECOMBINETICS INC.
  • ROQUETTE FRERES
  • ROYAL DSM NV
  • SANGAMO THERAPEUTICS INC.
  • SAREPTA THERAPEUTICS INC.
  • SCARAB GENOMICS LLC
  • SENTI BIOSCIENCES
  • SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
  • SIGMA ALDRICH CORP.
  • SHERLOCK BIOSCIENCES
  • SILICOLIFE LDA.
  • SOCATI CORP.
  • SPIBER INC.
  • STRING BIO
  • SUGARLOGIX
  • SYNBIO TECHNOLOGIES INC.
  • SYNGENTA AG (CHEMCHINA)
  • SYNTHEGO CORP.
  • SYNLOGIC THERAPEUTICS
  • SYNTHACE LTD.
  • SYNTHETIC BIOLOGICS INC.
  • TAKARA BIO
  • TEPHA INC.
  • TESELAGEN BIOTECHNOLOGY INC.
  • TIERRA BIOSCIENCES
  • TOOLGEN
  • TRANSCRIPTIC INC.
  • TROPIC BIOSCIENCES U.K. LTD.
  • TRITON ALGAE INNOVATIONS LTD.
  • VEDANTA BIOSCIENCES
  • VERSALIS SPA
  • VERTEX PHARMACEUTICALS INC.
  • VIR BIOTECHNOLOGY INC.
  • XYPHOS BIOSCIENCES, INC.
  • YIELD10 BIOSCIENCES INC.
  • ZIOPHARM ONCOLOGY, INC.
  • ZYMERGEN
  • ZYMOCHEM INC.

List of Tables

Summary Table : Global Market for Synthetic Biology, by Product Type, Through 2026
Table 1 : Report Scope
Table 2 : Synthetic Biology Paradigm
Table 3 : Driving Forces of the Market for Synthetic Biology, 2021-2026
Table 4 : Global Market for Synthetic Biology, by End-User Industry, Through 2026
Table 5 : Synthetic Biology Products and Technology Life Cycle Stage
Table 6 : Synthetic Biology Industry, by Market Segment
Table 7 : Synthetic Biology Definitions
Table 8 : Synthetic Biology History, 1970-2019
Table 9 : Paradigm Shift Caused by Synthetic Biology
Table 10 : Genetic Engineering and Synthetic Biology Comparison
Table 11 : Synthetic Biology Applications, by Technology
Table 12 : Importance of Enabling Technologies
Table 13 : Single Human Genome Sequence Cost, 2001-2021
Table 14 : DNA-Synthesis Costs, 2006-2019
Table 15 : Pros and Cons of Gene-Synthesis Technologies
Table 16 : Importance of Microfluidics Technologies in Synthetic Biology
Table 17 : Next-Generation Sequencing Technologies, by Company, 2019
Table 18 : Gene-Editing Therapeutic Interventions
Table 19 : Gene-Editing Technology Approaches
Table 20 : Comparison of the Major Gene-Editing Technologies
Table 21 : Comparison of CRISPR Enzyme Technology
Table 22 : Gene Drive Modified Organisms Potential Market Applications
Table 23 : Synthetic Biology Bioinformatics Technologies
Table 24 : Comparison of Nucleic Acids, Genes and Genomes
Table 25 : Synthetic DNA Types
Table 26 : Synthetic Genes as Molecular-Biology Tools
Table 27 : Synthetic Genes Versus Traditional Polymerase Chain Reaction Cloning
Table 28 : Mechanism of DNA Constructs
Table 29 : Minimal Genome Key Attributes
Table 30 : Enabled Technologies, by Near-Term Application
Table 31 : Metabolic Engineering for Artemisinic Acid
Table 32 : Research and Development Applications for Synthetic Biology Products
Table 33 : Microbiomes: Approaches of Incorporation of Synthetic Biology
Table 34 : Contribution of Synthetic Biology to Biofuels
Table 35 : Synthetic Biology Initiatives Relating to the Microbiome
Table 36 : Synthetic Biology Biosafety Governance Regulations
Table 37 : Synthetic Biology Products Impacted by Enabling Technologies
Table 38 : Biologic Components and Integrated Systems Near-Term Applications
Table 39 : Synthetic Gene Near-Term Applications, by End User
Table 40 : E Coli as a Chassis Organism
Table 41 : Drug Discovery and Development Applications for Synthetic Biology Products
Table 42 : Gene-Editing Clinical Pipeline, by Company, 2019
Table 43 : CAR-T Cell Alliances and Synthetic Biology Platforms
Table 44 : Industrial Biotechnology Applications
Table 45 : Synthetic Biology Enabled Biofuel Applications
Table 46 : Growth Status of Specialty versus Drop-in Biofuels, 2000–2020
Table 47 : Synthetic Biology Enabled Agriculture and Animal Applications
Table 48 : U.S. and European Approaches to Regulation of Gene-Edited Crops
Table 49 : Synthetic Biology Industry Structural Forces
Table 50 : Synthetic Biology Products and Technology Life Cycle Stages
Table 51 : Advanced Sequencing Industry Company Positioning, 2020
Table 52 : End-to-End Sequencing Approaches
Table 53 : Next Generation Sequencing History
Table 54 : Long-Read Sequencing Industry, by Company, 2020
Table 55 : Nucleic Acid Synthesis Key Competitor Strategies, by Company, 2020
Table 56 : RNA Therapy Segments
Table 57 : RNA Therapies Industry
Table 58 : Gene Synthesis Workflow
Table 59 : Gene Synthesis Market Factors of Differentiation
Table 60 : Gene-Editing Industry, 2020
Table 61 : Regulatory Situation of Gene-Edited Crops, by Country or Region
Table 62 : Clinical-Stage Gene-Editing Industry, 2020
Table 63 : Competitive Platforms: β-Thalassemia
Table 64 : Competitive Platforms: LCA, 2019
Table 65 : Organism Design and Automation Industry, 2020
Table 66 : Market Focus for Selected Synthetic Biology Software Companies, 2020
Table 67 : Market Segment of Synthetic Biology Agriculture Industry, by Company, 2020
Table 68 : Consumer Products Industry Market Segment, by Company, 2020
Table 69 : Cosmetic and Skin Care Industry, 2020
Table 70 : Food and Beverage Industry, 2020
Table 71 : Synthetic Biology-Based Healthcare Industry, 2020
Table 72 : Microbiome Therapeutic Industry, 2020
Table 73 : Synthetic Biology-Based Industrial Chemicals Industry, 2020
Table 74 : Leading Companies in the Cell-Free Synthetic Biology Industry, 2020
Table 75 : Synthetic Biology Industry Acquisitions, 2018–2021
Table 76 : Strategic Alliances, 2018–2020
Table 77 : Forces Driving Growth in the Market for Synthetic Biology
Table 78 : Global Market for Synthetic Biology in Research End Uses, by Product Type, Through 2026
Table 79 : Global Market for Synthetic Biology in Healthcare End Uses, by Product Type, Through 2026
Table 80 : Global Market for Synthetic Biology in Industrial Chemical End Uses, by Product Type, Through 2026
Table 81 : Global Market for Synthetic Biology in Agricultural End Uses, by Product Type, Through 2026
Table 82 : Global Market for Synthetic Biology in Consumer End Uses, by Product Type, Through 2026
Table 83 : Global Market for Synthetic Biology in Food and Beverage End Uses, by Product Type, Through 2026
Table 84 : Global Market for Synthetic Biology, by Product Type, Through 2026
Table 85 : Global Market for Synthetic Biology Enabling Products, by Type, Through 2026
Table 86 : Global Market for Synthetic Biology Enabling Products, by End-User Industry, Through 2026
Table 87 : Global Market for Synthetic Biologic Components, by Type, Through 2026
Table 88 : Global Market for Synthetic Biologic Components, by End-User Industry, Through 2026
Table 89 : Global Market for Synthetic Biology Integrated Systems, by Type, Through 2026
Table 90 : Synthetic Biology Microbe Engineering Workflow
Table 91 : Global Market for Synthetic Biology Integrated Systems, by End-User Industry, Through 2026
Table 92 : Biodiesel Fuel Performance Comparison
Table 93 : Artemisinin Drug Production Comparison
Table 94 : Sweetener Product Comparison
Table 95 : Global Market for Synthetic Biology Enabled Products, by End-User Industry, Through 2026
Table 96 : Global Market for Synthetic Biology Enabled Products in Healthcare End-Use, by Segment, Through 2026
Table 97 : Gene-Editing Clinical Pipeline, by Company, 2019
Table 98 : Global Market for Synthetic Biology Enabled Products in Consumer End-Use, by Type, Through 2026
Table 99 : Global Market for Synthetic Biology Enabled Products in Food and Beverage End-Use, by Type, Through 2026
Table 100 : Synthetic Biology-Based Chemical Process Factors
Table 101 : Global Market for Synthetic Biology Enabled Products in Industrial Chemical End-Use, by Type, Through 2026
Table 102 : Advanced Biofuel Growth Factors
Table 103 : Crude Oil Prices, 2011-2020
Table 104 : Strategic Shifts in Biofuels, by Company, 2012–2018
Table 105 : Global Market for Synthetic Biology Enabled Products in Agriculture End-Use, by Type, Through 2026
Table 106 : Mosquito-Control Methods
Table 107 : Aedes Aegypti Initial Markets, 2019
Table 108 : Advantages of Gene Editing for Crop Enhancement
Table 109 : Gene-Edited Crop Market Landscape, 2020
Table 110 : Gene Edited Crops Commercialization Pathway
Table 111 : Global Market for Synthetic Biology, by Region, Through 2026
Table 112 : Global Market for Synthetic Biology Enabling Products, by Region, Through 2026
Table 113 : Global Market for Synthetic Biologic Components, by Region, Through 2026
Table 114 : Global Market for Synthetic Biology Integrated Systems, by Region, Through 2026
Table 115 : Global Market for Synthetic Biology Enabled Products, by Region, Through 2026
Table 116 : Patents on Synthetic Biology Technologies
Table 117 : Foundational Patents on Synthetic Biology Technolgies
Table 118 : Synthetic Biology Representative Patent Grouping, by Tier
Table 119 : Patent Description, by Company
Table 120 : Status of Liquid Biopsy and Sequencing-Related Patent Disputes, 2019
Table 121 : CRISPR-Cas9 Patent Groups
Table 122 : CRISPR-Cas9 Patent Licensing Fields, by Company
Table 123 : Sangamo Collaboration Agreements Relating to ZFN Technology
Table 124 : Sangamo Therapeutics Patent Position
Table 125 : Ginkgo Bioworks Engineered-Organism Workflow
Table 126 : Agrivida Technical Approach
Table 127 : Arcturus Therapeutics Inc.: Multiple mRNA Vaccine and Therapeutic Programs in Clinical Development
Table 128 : Gene-Editing Versus Gene-Therapy Approach

List of Figures

Summary Figure : Global Market for Synthetic Biology, by Product Type, 2019-2026
Figure 1 : Value Chain Analysis
Figure 2 : Synthetic Biology Value Added Chain
Figure 3 : Evolution of Synthetic Biology from Natural to Artificial Systems
Figure 4 : Conventional Versus Synthetic Biology Approach to Gene Synthesis
Figure 5 : Synthetic Biology Scale
Figure 6 : Conventional DNA-Synthesis Technology Schematic
Figure 7 : Microarrays in DNA Synthesis
Figure 8 : Promoter and Reporter Roles in Synthetic Biology Systems
Figure 9 : Creation of Enabled Products Through Synthetic Biology
Figure 10 : Total Synthetic Biology Funding, 2017–2020
Figure 11 : Industrial Biotechnology Value Chain with Synthetic Biology Leverage Points
Figure 12 : Synthetic Biology Patent Documents Granted, Filed and Published, 2018–2021
Figure 13 : Agilent Technologies: Annual Revenue, 2018–2020
Figure 14 : Agilent Technologies: Revenue Share, by Segment, 2020
Figure 15 : Agilent Technologies: Revenue Share, by Region, 2020
Figure 16 : Amyris Inc.: Annual Revenue, 2018–2020
Figure 17 : Amyris Inc.: Revenue Share, by Region, 2020
Figure 18 : Codexis Inc.: Annual Revenue, 2018–2020
Figure 19 : Codexis Inc.: Revenue Share, by Segment, 2020
Figure 20 : Codexis Inc.: Revenue Share, by Region, 2020
Figure 21 : Eurofins Scientific: Annual Revenue, 2018–2020
Figure 22 : Eurofins Scientific: Revenue Share, by Region, 2020
Figure 23 : GenScript: Annual Revenue, 2018–2020
Figure 24 : GenScript: Revenue Share, by Segment, 2020
Figure 25 : GenScript: Revenue Share, by Region, 2020
Figure 26 : Merck KGaA: Annual Revenue, 2018–2020
Figure 27 : Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 28 : Merck KGaA: Revenue Share, by Region, 2020
Figure 29 : Novozymes A/S: Annual Revenue, 2018–2020
Figure 30 : Novozymes A/S: Revenue Share, by Business Segment, 2020
Figure 31 : Novozymes A/S: Revenue Share, by Region, 2020
Figure 32 : Thermo Fisher Scientific: Annual Revenue, 2018–2020
Figure 33 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020
Figure 34 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 35 : Twist Bioscience: Annual Revenue, 2018–2020
Figure 36 : Twist Bioscience: Revenue Share, by Products, 2020
Figure 37 : Twist Bioscience: Revenue Share, by Region, 2020


△ 一番上に戻る